Deye(SH:605117)2024-04-24 11:28Financial Performance - The company's operating revenue for Q1 2024 was CNY 1,883,732,255.41, representing a decrease of 9.64% compared to the same period last year[5]. - The net profit attributable to shareholders was CNY 432,908,176.82, down 26.48% year-on-year[5]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 424,687,234.96, a decline of 19.04%[5]. - The basic earnings per share for the period was CNY 1.01, reflecting a decrease of 26.23%[6]. - Total operating revenue for Q1 2024 was CNY 1,883,732,255.41, a decrease of 9.6% compared to CNY 2,084,721,951.30 in Q1 2023[23]. - Net profit for Q1 2024 was CNY 432,908,176.82, a decline of 26.5% from CNY 588,816,014.50 in Q1 2023[24]. - Basic and diluted earnings per share for Q1 2024 were CNY 1.01, down from CNY 1.37 in Q1 2023, representing a decline of 26.3%[25]. Cash Flow and Assets - The net cash flow from operating activities was CNY 130,457,282.09, down 82.48% compared to the previous year[10]. - The company's cash and cash equivalents decreased to CNY 852,991,495.69 in Q1 2024 from CNY 1,533,707,589.19 in Q1 2023, a significant drop of 44.4%[21]. - Cash inflow from operating activities totaled CNY 1,518,360,408.27, a decrease of 13.8% from CNY 1,760,590,483.23 in the same period last year[28]. - The net cash flow from operating activities was CNY 130,457,282.09, significantly lower than CNY 744,784,958.80 in Q1 2023, indicating a decline of 82.5%[28]. - The company's cash and cash equivalents at the end of Q1 2024 were CNY 3,766,038,832.99, an increase from CNY 3,466,706,811.19 at the end of Q1 2023[29]. - The company experienced a significant decline in cash flow due to reduced revenue and increased prepayments for battery cells[10]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 11,406,000,987.66, an increase of 5.44% from the end of the previous year[6]. - The company's total assets increased to CNY 11,406,000,987.66 in Q1 2024, up from CNY 10,817,384,018.87 in Q1 2023, representing a growth of 5.4%[22]. - Total liabilities rose to CNY 5,682,480,087.43 in Q1 2024, compared to CNY 5,585,950,423.64 in Q1 2023, indicating an increase of 1.7%[21]. - The equity attributable to shareholders increased by 9.41% to CNY 5,723,520,900.23 compared to the end of the previous year[6]. - The company's equity attributable to shareholders increased to CNY 5,723,520,900.23 in Q1 2024, compared to CNY 5,231,433,595.23 in Q1 2023, reflecting a growth of 9.4%[22]. Shareholder Information - The company reported no significant changes in the shareholder structure or participation in margin financing activities during the reporting period[15]. - The top ten shareholders did not engage in margin financing, and the participation in the transfer of shares was detailed in the report[15]. Research and Development - Research and development expenses for Q1 2024 were CNY 97,542,040.57, down from CNY 115,696,296.47 in Q1 2023, a reduction of 15.7%[23]. - The company has not disclosed any new product developments or technological advancements in this quarter[18]. Future Outlook and Guidance - The company has not provided specific future guidance or performance outlook in the current report[18]. - There are no significant mergers or acquisitions reported during this period[18]. Financial Reporting - The report indicates that the financial statements are unaudited, which may affect the reliability of the financial data presented[18].